J B Chemicals and Pharmaceuticals Share Price

J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing medicated and herbal lozenges. It produces hard-candy lozenges, soft-center lozenges and powder-filled lozenges for varied medical needs. Its API products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Nifedipine, and others. It maintains a direct presence in Russia and South Africa, while leveraging distributor partnerships across the United States, Asia, Africa, and Latin America.As of 30 May 2026, J B Chemicals and Pharmaceuticals share price is ₹2,167.40. The stock opened at ₹2,204.20, compared to its previous close of ₹2,204.20. During today's trading session, J B Chemicals and Pharmaceuticals share price moved in the range of ₹2,131.00 to ₹2,239.80, with an average price of ₹2,185.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,131.00 and a high of ₹2,239.80. On the performance front, J B Chemicals and Pharmaceuticals share price has increased by 22.36% over the last six months and is up 28.22% on a year-on-year basis.

The market capitalization of J B Chemicals and Pharmaceuticals is ₹34,881 Crs, with a P/E ratio of 49.2 and a dividend yield of 1.07%.